Article Details
Retrieved on: 2024-04-03 13:12:09
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Actinium Pharmaceuticals Inc.'s participation in the Canaccord Genuity event, highlighting its biopharma focus on targeted treatments for cancer, using actinium compounds, and includes forward-looking statements.
Article found on: uk.news.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here